← Browse by Condition
Medical Condition
glioblastoma idh wildtype
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 2, Phase 2
NCT05941234
Recruiting
Stem Cell Analysis, Omics (Including Immunomics) and Artificial Intelligence in Glioblastoma
Enrollment
120 pts
Location
Italy
Sponsor
Fondazione Policlinico Univers...
NCT06047379 Phase 1, Phase 2
Recruiting
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Enrollment
134 pts
Location
United States
Sponsor
Neonc Technologies, Inc.
NCT06327451 Phase 2
Recruiting
Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma
Enrollment
50 pts
Location
China
Sponsor
Tianjin Medical University Gen...